Fortress Biotech, Inc. (FBIO) vs Heron Therapeutics, Inc. (HRTX)
A side-by-side comparison of Fortress Biotech, Inc. and Heron Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
FBIO
Fortress Biotech, Inc.
$2.04HealthcareDelayed quote: Oct 6, 2026, 10:40 AM EDT
HRTX
Heron Therapeutics, Inc.
$0.34HealthcareDelayed quote: Oct 6, 2026, 10:40 AM EDT
Total return — FBIO vs HRTX
growth of $100 · dividends reinvested · last 10yFBIO -95.1% (-26.1%/yr)HRTX -97.7% (-31.4%/yr)FBIO compounded faster over this window
FBIO HRTX
FBIO vs HRTX: by the numbers
- •FBIO is the larger company ($68M vs $65M market cap).
- •FBIO is profitable (163.32% net margin) while HRTX runs a net loss (-22.52%).
- •HRTX grew revenue faster over the past five years (12.73% vs 5.39% CAGR).
Metrics side by side
Valuation
| Metric | FBIO | HRTX |
|---|---|---|
| P/E ratio | 0.76 | N/A |
| P/S ratio | 0.99 | 0.43 |
| P/B ratio | 0.41 | 11.09 |
| FCF yield | 186.15% | N/A |
Profitability
| Metric | FBIO | HRTX |
|---|---|---|
| Gross margin | 62.53% | 70.07% |
| Operating margin | -111.00% | -7.19% |
| Net margin | 163.32% | -22.52% |
| ROE | 68.12% | -492.89% |
| ROIC | -10.85% | -6.79% |
Growth (annualized)
| Metric | FBIO | HRTX |
|---|---|---|
| Revenue CAGR (5Y) | 5.39% | 12.73% |
| Total return CAGR (5Y) | -46.06% | -48.61% |
Frequently asked
- Which has grown faster, FBIO or HRTX?
- Over the past five years, HRTX grew revenue faster — FBIO at a 5.39% CAGR versus HRTX at 12.73%.
- Is FBIO or HRTX more profitable?
- FBIO runs the higher net margin — FBIO at 163.32% versus HRTX at -22.52%.
- How have FBIO and HRTX total returns compared?
- Over the past 10 years, FBIO delivered -26.29% and HRTX delivered -31.88% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Fortress Biotech P/E ratioFortress Biotech ROEHeron Therapeutics ROEFortress Biotech operating marginHeron Therapeutics operating marginFortress Biotech revenue growthHeron Therapeutics revenue growthFortress Biotech free cash flowHeron Therapeutics free cash flow
Fortress Biotech & Heron Therapeutics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.